コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 bined brain quantitative morphometry in this setting.
2 s of colonoscopy surveillance in a screening setting.
3 tients more representative to the real-world setting.
4 between genotype and phenotype in an in vivo setting.
5 ons in chemical biology and in a therapeutic setting.
6 rious surfaces depending on the geographical setting.
7 ng blood cultures in an Emergency Department setting.
8 ings support prehospital transfusion in this setting.
9 suicide and euthanasia in the critical care setting.
10 more HER2-directed regimens in the advanced setting.
11 e development of cardiac dysfunction in this setting.
12 in the long-term acute care hospital (LTACH) setting.
13 brosis, are needed in the general population setting.
14 ld never be done outside of a clinical trial setting.
15 is no established therapy in the second-line setting.
16 ldren was well-newborn care in the inpatient setting.
17 smission characteristics of MRSA in hospital setting.
18 ct to maximize ANPP in a given environmental setting.
19 antiretroviral therapy in a resource-limited setting.
20 th acquired and intrinsic resistance in this setting.
21 use in adjuvant or neoadjuvant vs palliative setting.
22 ision making when applying TDM in a reactive setting.
23 optimal duration for stents in this clinical setting.
24 een tracheal intubation and survival in this setting.
25 n criteria were recruited in a memory clinic setting.
26 ent of collaborative care models for the ICU setting.
27 investigated this relationship in a European setting.
28 e antithrombotic agent for use in a hospital setting.
29 psis-3) criteria in the emergency department setting.
30 ect test of this hypothesis in a whole-brain setting.
31 tput, and stroke volume in the perioperative setting.
32 nd maintenance activities in a manufacturing setting.
33 based chemotherapy regimen in the metastatic setting.
34 g approach for translation into the clinical setting.
35 tatic and, to a limited extent, the adjuvant setting.
36 Second-line VF was frequent in this setting.
37 ical findings are relevant for the pediatric setting.
38 chance of being cost-effective in the study setting.
39 f cognitive dysfunction in the perioperative setting.
40 ired signaling pathway(s) for S100A4 in this setting.
41 iciency virus (HIV) status in an HIV-endemic setting.
42 duced lncRNAs were dispensable in the normal setting.
43 ext is highly applicable in the metagenomics setting.
44 curately estimate visceral fat in a clinical setting.
45 tologic care in a public safety-net hospital setting.
46 evaluate the evidence for their use in this setting.
47 safety of care provided to children in this setting.
48 further studies of avelumab in this disease setting.
49 d utility for predicting mortality in an ICU setting.
50 effectiveness of icatibant in the real-world setting.
51 mab as a new standard-of-care option in this setting.
52 s use for individual diagnosis in a clinical setting.
53 ble for clinical use outside of the research setting.
54 d family-centered care in the intensive care setting.
55 tion for patient discussions in the clinical setting.
56 nitoring of modifiable risks in the clinical setting.
57 ood glucose meters in critically ill patient settings.
58 ent increases in wasting in humanitarian aid settings.
59 t poorly implemented in resource-constrained settings.
60 , informed by previous experience in similar settings.
61 erm studies (hours) in controlled laboratory settings.
62 cause of childhood mortality in low-resource settings.
63 ds by applying prior knowledge gained in new settings.
64 has not been assessed in routine healthcare settings.
65 ould be useful in both clinical and research settings.
66 long term, their usefulness in agricultural settings.
67 V-associated cancers in resource-constrained settings.
68 o humans in both agricultural and ecological settings.
69 fit with patient/nurse interactions in ward settings.
70 lcitrant biofilms in clinical and industrial settings.
71 ector-cell engagement in various therapeutic settings.
72 different consequences in different clinical settings.
73 er understanding of biology in physiological settings.
74 al genomics of different species in numerous settings.
75 umidity), such as those found in health care settings.
76 ype I interferons in many different clinical settings.
77 are common in both inpatient and outpatient settings.
78 tial gaps in quality of care persist in both settings.
79 o severe childhood diarrhea in resource-poor settings.
80 parametric regression in observational data settings.
81 144 weeks of follow-up in typical programme settings.
82 ot received detailed consideration for these settings.
83 ostics in preclinical and clinical oncologic settings.
84 ined higher power than other methods in some settings.
85 l mechanotype in basic research and clinical settings.
86 ion must be targeted to high-risk groups and settings.
87 approach in a variety of sub-Saharan African settings.
88 parity for different geographic and security settings.
89 eterisation-are already used in low-resource settings.
90 e utility of such assays in resource limited settings.
91 appropriate, of studies in resource-limited settings.
92 s remains a challenging task in genome scale settings.
93 s required to halt transmission in different settings.
94 how these features can be used in industrial settings.
95 likely to be of diagnostic value in clinical settings.
96 ence decreased notably in undisturbed forest settings.
97 s and devices to be used in resource-limited settings.
98 conomically disadvantaged women in different settings.
99 r refute outbreaks in hospital and community settings.
100 racticality and translatability for clinical settings.
101 city have increased in research and clinical settings.
102 ieved using aflibercept for nAMD in clinical settings.
103 se to Ebola virus disease outbreaks in rural settings.
104 that used high-grade equipment in laboratory settings.
105 promote functional recovery in translatable settings.
106 fing and training, often in resource-limited settings.
107 their environmental health benefits in field settings.
108 ranscript and protein levels in a variety of settings.
109 nd treatment efficacy across various disease settings.
110 in healthcare that exist in limited-resource settings.
111 ps that embed criminologists within carceral settings.
112 situ sensor array operation in low resource settings.
114 OPV, and such preparation would be aided by setting a reasonably firm date for OPV withdrawal as far
117 e-selective catalysis in a complex molecular setting also delivered synergistic insights in the arena
118 drial catabolic capacity is a key constraint setting an upper limit on the rate of cofactor productio
119 lidate consensus equation in a perioperative setting analyses of cases of suspected perioperative ana
120 ion for human disease in a natural great ape setting and have potential conservation implications in
122 ficant liver disease in a general population setting and report the prevalence of chronic liver disea
124 TAG's role as observed in 2 particular local settings and applied to a global public health issue, th
125 use of handheld devices in various clinical settings and by different users, proficiency in point-of
126 arch should validate this checklist in other settings and compare its results with other measures.
130 ems that is transferable to other low-income settings and that garners political will, builds capacit
131 ith both trastuzumab and lapatinib (advanced setting) and a taxane (any setting) and with progression
132 patinib (advanced setting) and a taxane (any setting) and with progression on two or more HER2-direct
133 ated visual working memory in a more dynamic setting, and assessed the following: (1) whether interna
135 n trauma care, in both military and civilian settings, and presents directions for future research.
137 in diverse sample types, but in the clinical setting are limited by overwhelming host material and ul
140 e care presence and integration into the ICU setting, as well as acceptability of 23 published pallia
141 s study was performed in a clinical/surgical setting at Retina Consultants of Houston and Houston Met
142 sers to choose between different methods for setting B-factors and the number of models used for phas
143 iously treated in an academic medical center setting between 2009 and 2012 for chest wall disease tha
144 noses was life threatening in the ambulatory setting, but approximately 16% of diplopia-related ED vi
145 d object knowledge in constrained laboratory settings, but also allows researchers to tackle real-wor
146 are being investigated in multiple clinical settings, but drug resistance may reduce their benefit.
147 s a serious complication in various clinical settings, but the mechanisms driving it remain to be ful
148 the slab in an advancing upper plate-motion setting can locally impede rollback and maintain flat sl
150 nal EHR data, commonly available in clinical settings, can be useful for predicting future risk of su
151 Here, we report a powerful impact in this setting caused by epigenetic upregulation of glutamate d
153 elivery method to treat PSBI in low-resource settings could decrease user error and expand access to
154 gy between LAG3 and PD1 observed in multiple settings, coupled with the contrasting intracellular cyt
155 osynthetic organic matter in a soft-sediment setting creates geochemically diverse environments, whic
157 A total of 86 participants from a TB-endemic setting, either HIV-infected or uninfected and with late
159 occurring across a wide range of ecological settings, especially when environmental conditions are c
161 inappropriate often applied in institutional settings, fails to account for complex factors that may
164 he emergency department (ED) is an opportune setting for initiating suicide prevention efforts, ED-in
165 have important implications in the clinical setting for the development of metastasis-specific drugs
166 celeration, is not currently considered when setting fuel economy and greenhouse-gas emission standar
167 nt of in vivo relevance in different disease settings has been hampered by limited tools to quantify
168 of facility-based childbirth in low-resource settings has increased dramatically during the past two
171 da and Kenya, selected on the basis of rural setting, having an approximate population of 10 000 peop
173 from 1 outpatient department and 1 inpatient setting in Apac District, Uganda, from July 2009 through
176 has not been evaluated in primary care, the setting in which most people with GFR in this range are
178 ternal validity in terms of applicability to settings in low and middle income countries is questiona
180 rrently in clinical trials in the transplant setting include keratinocyte growth factor, cytokines (I
181 ains of health and health services in crisis settings, including population size and composition, exp
182 between riverine and nonriverine geomorphic settings indicates that the availability of mineral sedi
184 d method of BP measurement in the outpatient setting is essential to ensure proper monitoring and gau
187 essment of Health Plans Survey in ambulatory settings is incorporated as a complementary value metric
192 antable hemodynamic technology in a nontrial setting leads to significant lowering of PA pressures.
195 Patients with minimal and stable ventilator settings may be suitable candidates for early antibiotic
196 ce suggested that P4P programs in ambulatory settings may improve process-of-care outcomes over the s
197 must be validated in primary and urgent care settings, may help clinicians make a provisional diagnos
200 n ILTCFs suggests that the ecosystem in such settings might be more conducive for intrafacility trans
201 of hormone concentrations with geographical setting, nutritional status, and physical activity level
202 s, with CaP and SLA surfaces requiring power setting of 1.0 to 1.5 W for ablation of bacteria coating
203 ting their choice, participants adjusted the setting of a clock to the moment they felt they had reac
206 differences underlie arrhythmia risk in the setting of acute sympathetic nervous system discharge.
208 We examined the role of neuroimaging in the setting of autoimmune encephalitides, comparing the util
216 in rifampicin-susceptible tuberculosis in a setting of high human immunodeficiency virus type 1 (HIV
219 FOXD3-AS1, known as linc1623 in mice, in the setting of hyperoxia/reactive oxygen species (ROS)-induc
221 ernative noncatecholaminergic support in the setting of inflammatory cardiovascular dysfunction.
224 Food-specific IgG antibodies arise in the setting of naturally resolving food allergy and accompan
229 atients at high risk of developing HF in the setting of right ventricular pacing and to determine whe
233 hat when glucagon activity is blocked in the setting of type 1 diabetes, the plasma ghrelin level ris
236 ety and efficacy in preventing acute GVHD in settings of heightened clinical risk that use myeloablat
239 in receptor, and retinol binding protein) in settings of prevalent inflammation as well as the preven
242 anisotropic fabrics, widespread in orogenic settings, on the mechanical behaviour of crustal rocks a
243 h care professionals who worked in the acute setting or had no experience of re-use were most resista
244 extinction of native remnant plants in urban settings, or whether they could have other effects that
247 INTERPRETATION: In China's primary care setting, pragmatic interventions on antimicrobial stewar
248 erformance of single-agent melphalan in this setting prompted us to study a new high-dose combination
249 e many MERS cases are acquired in healthcare settings, public health measures and scrupulous attentio
250 hole-exome sequencing (WES) in the pediatric setting requires an understanding of who should be consi
251 s somite patterning, rostral-caudal boundary setting, specialization of myotome subdivisions or the s
253 ptoms elicited in primary mental health care settings suggest that symptoms alone are not useful in p
255 eview of evidence for antibiotic use in this setting that included recent clinical guidelines from pr
256 ically' reconfigurable at run-time simply by setting the amplitude of the clock pulse applied to the
257 ely tuned to regulate stochastic expression, setting the ratio of alternative fates and ultimately de
259 ay underpin a profound immune dysregulation, setting the stage for disease manifestations characteris
260 ly growing members of the order Rhizobiales, setting the stage for in-depth analyses of the molecular
261 vior perfectly followed the predicted model, setting the stage for more advanced motors for functiona
263 en DKO prostate tumor organoids grew larger, setting the stage to translate mouse model findings to p
266 It is emphasized that in organizational settings, the responses to same-sex attractive others ar
267 nign one is very challenging in the surgical setting; therefore, accurate recognition is important to
268 tudy, we tested current paradigms on factors setting thermal limits by investigating the acute warmin
270 by farm staff is impractical in a commercial setting to the degree required to detect behavioural cha
271 K4me1 on cis-regulatory elements in specific settings to fine-tune transcriptional regulation in resp
279 preventive services and cancer care in this setting, we found higher mortality for AIAN than NHW wit
280 ce and predictors of inflammation in diverse settings.We aimed to assess the relation between inflamm
285 lume method have the best reproducibility in settings where assessment is not performed by the same p
287 w period in blood donors in resource limited settings where nucleic acid testing is not practical or
288 failure of model convergence, especially in settings where the prevalence of M. tuberculosis infecti
289 ever, its performance in routine health care settings, where adherence to drug treatment is unsupervi
290 Participants were monitored in an outpatient setting with daily clinical review and collection of blo
291 lus (anaerobic), was performed in a clinical setting with patient samples in a matched system design
292 United States, but its use worldwide and in settings with inflammation has been limited.We examine w
293 0.6 million] of all pregnancies) occurred in settings with near-perfect SP curative efficacy (>99%) b
294 hirds of the studies were performed in urban settings with predominantly African-American women (n=27
295 This requirement is difficult to meet in settings with sensitive data, which can mean that result
296 ants who received CRC care in a clinic-based setting without preselection for age at diagnosis, perso
297 socomial ESBL-EC transmission in nonepidemic settings, without harming patient safety, providing suff
299 ioid use disorder (OUD) in U.S. primary care settings would expand access to treatment for this condi
300 policy optimized for middle-income resource settings yields 0.008 fewer QALYs per person, but saves
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。